Obinutuzumab for Follicular Lymphoma User Reviews
Brand names: Gazyva
- Buc...
- Taken for 2 to 5 years
- May 26, 2022
"I received obinutuzumab plus bendamustine for follicular lymphoma. After 6 months of treatment, the lymphoma went into remission. Then I continued on with obinutuzumab only for 2 years. I mostly struggled with fatigue, bloating, UTIs, and bladder pain, shortness of breath, and occasional headaches. The medication was administered through my port every 8 weeks once I was on maintenance."
- Pjm...
- Taken for less than 1 month
- January 30, 2025
"My oncologist switched me to obinutuzumab following a reaction to Rituxan after four courses of chemo RCHOP. So far, I have no issues after two fusions with three more to go. Very happy since obinutuzumab is apparently more effective."
Frequently asked questions
- M W...
- Taken for 1 to 6 months
- July 13, 2025
"After the second dose, it wiped out my immune system, and I was hospitalized for 4 months. I suffered multiple infections, and the infection disease doctors wanted to make me a DNR on several occasions. If it hadn't been for my wife asking for a second opinion, I wouldn't be here today. I personally don't recommend Gazyva use for anyone."
See also:
Learn more about Follicular Lymphoma
Care guides
More about obinutuzumab
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
"I was diagnosed with stage 4 follicular lymphoma in December 2021 and received 6 months of chemotherapy with obinutuzumab and bendamustine. All went well except for tiredness, especially towards the end of the 6-month cycle, and a lot of 'burping.' Scans showed that I am now in partial remission. I have since had two treatments of maintenance therapy and am starting to feel well again. I am very grateful to all the people who have developed such lifesaving therapy."